OSTX
OS Therapies Incorporated
NYSE MKT: OSTX · HEALTHCARE · BIOTECHNOLOGY
$1.70
+4.29% today
Updated 2026-04-30
Market cap
$77.20M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.98
Dividend yield
—
52W range
$1 – $3
Volume
0.6M
OS Therapies Incorporated (OSTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-914.00%
ROA
-289.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-6027.00 | — | — | — |
| 2021 | $0.00 | $-7.42M | — | — | — |
| 2022 | $0.00 | $-6.25M | — | — | — |
| 2023 | $0.00 | $-7.79M | — | — | — |
| 2024 | $0.00 | $-8.88M | — | — | — |
| 2025 | $0.00 | $-28.75M | — | — | — |